A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Completed

• Conditions: Parkinson's Disease; Malignant Melanoma

• Registration Number: NCT00203008
• Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Brief Summary

Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-01
• Study Completion: 2003-09
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-20
• Status Verified: 2010-10
• Last Update Submitted: 2010-10-14
• Last Update Posted: 2010-10-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2106

Inclusion Criteria

Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment

Exclusion Criteria

unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified